2 Biotech ETFs Differ Greatly in Constituents


2 Biotech ETFs Differ Greatly in Constituents

Related Stocks: BBH, PBE Nick Perry (Schaeffer's Investment Research) submits: The most important point to me in evaluating ETFs is to know what stocks make up the ETF and how those stocks are weighted. The best source of this information is usually found on sites run by the ETF families. The list below shows a few of the ones from my bookmarks that I find myself regularly visiting: Complete Story »

You might be interested in these entries too:

Biotech Week in Review: Onyx Is Star of the Week

Centient Biotech Investor submits: A very minor advance was the best that biotech could do last week. The Centient Biotech 200™ rose just 4 points, which equates...

Biosimilars And China: A Natural Combination, But Will It Happen?

ChinaBio Today submits: Biosimilars are the closest thing that the biotech world has to generic drugs. However, because biotech drugs are grown in cultures, rather...

Responses to '2 Biotech ETFs Differ Greatly in Constituents'


  1. No Comments

Leave a Reply





eXTReMe Tracker